Up-regulation of endothelin-B receptors in atherosclerotic human coronary arteries

Journal of Cardiovascular Pharmacology

Volumn 27, Issue 1, 1996, Pages 147-153

  Dagassan, Patrick H ^a   Breu, Volker ^a   Clozel, Martine ^a   Künzli, Andreas ^b   Vogt, Paul ^b   Turina, Marko ^b   Kiowski, Wolfgang ^b   Clozel, Jean Paul ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Atherosclerosis; Cardiomyopathy; Competition binding; Endothelin receptors; Human coronary arteries; Porcine

Indexed keywords

BOSENTAN; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN RECEPTOR; SARAFOTOXIN S6C;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; HUMAN; HUMAN TISSUE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECEPTOR DENSITY; SWINE;

ACETYLCHOLINE; ADULT; CORONARY ARTERIOSCLEROSIS; HUMANS; MIDDLE AGED; PEPTIDES, CYCLIC; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN; SULFONAMIDES; UP-REGULATION; VASOCONSTRICTOR AGENTS; VIPER VENOMS;

EID: 0030063833     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199601000-00023     Document Type: Article

References (44)

1. 2 + channels. J Hypertens [Suppl] 1988;6:S188-91.
2. Battistini B, Warner TD, Corder R. Update on endothelin research. Drug News Perspect 1994;7:249-53.
3. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990;348:730-2.
4. Sakurai T, Yanagisawa M, Takuwa Y, et al. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 1990;348:732-5.
5. C receptor) from Xenopus laevis dermal melanophores. J Biol Chem 1993;268:19126-33.
6. Kumar C, Mwangi V, Nuthulaganti P, et al. Cloning and characterization of a novel endothelin receptor from Xenopus heart. J Biol Chem 1994;269:13414-20.
7. Yanagisawa M. The endothelin system: a new target for therapeutic intervention. Circulation 1994;89:1320-2.
8. Hay DWP, Luttmann MA, Hubbard WC, Undem BJ. Endothelin receptor subtypes in human and guinea-pig pulmonary tissues. Br J Pharmacol 1993;110:1175-83.
9. B receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 1994;89: 1203-8.
10. A receptors in humans? Trends Pharmacol Sci 1994;15:9-11.
11. Godfraind T. Endothelin receptors in human coronary arteries. Trends Pharmacol Sci 1994;15:136.
12. B receptors in human vascular smooth muscle. J Cardiovasc Pharmacol 1993;22:822-5.
13. 125I]Endothelin-l binding to vasa vasorum and regions of neovascularization in human and porcine blood vessels: a possible role for endothelin in intimal hyperplasia and atherosclerosis. J Cardiovasc Pharmacol 1993;22:8343-7.
14. 125I]-ET-1 binding to the atherosclerotic human coronary artery. Br J Pharmacol 1994;112:386-9.
15. Pernow J, Modin A. Endothelial regulation of coronary vascular tone in vitro: contribution of endothelin receptor subtypes and nitric oxide. Eur J Pharmacol 1993;43:281-6.
16. Schoeffter P, Randriantsoa A. Differences between endothelin receptors mediating contraction of guinea-pig aorta and pig coronary artery. Eur J Pharmacol 1993;249:199-206.
17. Harrison VJ, Randriantsoa A, Schoeffter P. Heterogeneity of endothelin-sarafotoxin receptors mediating contraction of pig coronary artery. Br J Pharmacol 1992;105:511-3.
18. Clozel M, Breu V, Gray GA, et al. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J Pharmacol Exp Ther 1994;270:228-35.
19. A receptor. Life Sci 1992;50:247-55.
20. Fischli W, Clozel M, Guilly C. Specific receptors for endothelin on membranes from human placenta. Characterization and use in a binding assay. Life Sci 1989;44:1429-36.
21. Lowry OH, Roseborough NJ, Farr AL, Randall RJ. Protein measurement with the Folin reagent. J Biol Chem 1951;193: 265-75.
22. B receptors. FEBS Lett 1993;334: 210-4.
23. Munson PV, Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 1980;107:220-39.
24. Ross G, Stinson E, Schroeder J, Ginsburg R. Spontaneous phasic activity of isolated human coronary arteries. Cardiovasc Res 1980;14:613-8.
25. 2α and depolarization. Am J Cardiol 1989;64:58-64.
26. B receptor mediates both vasodilation and vasoconstriction in vivo. Biochem Biophys Res Commun 1992;186:867-73.
27. Godfraind T. Evidence for heterogeneity of endothelin receptor distribution in human coronary artery. Br J Pharmacol 1993;110:1201-5.
28. Ihara M, Saeki T, Funabashi K, et al. Two endothelin receptor subtypes in porcine arteries. J Cardiovasc Pharmacol 1991;17:S119-21.
29. Bax WA, Bruinvels AT, Van SRJ, Saxena PR, Hoyer D. Endothelin receptors in the human coronary artery, ventricle and atrium. A quantitative autoradiographic analysis. Naunyn Schmiedebergs Arch Pharmacol 1993;348:403-10.
30. Molenaar P, O'Reilly G, Sharkey A, et al. Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circ Res 1993;72:526-38.
31. Elshourbagy NA, Korman DR, Wu HL, et al. Molecular characterization and regulation of the human endothelin receptors. J Biol Chem 1993;268:3873-9.
32. 125I]endothelin-l in humans, pigs, and rats: functional relevance in humans. J Cardiovasc Pharmacol 1989;13: S166-70.
33. AHA Committee Report. A reporting system on patients evaluated for coronary artery disease. Circulation 1975;1: IV.5-40.
34. Chester AH, O'Neil GS, Allen SP, Luu TN, Tadjkarimi S, Yacoub MH. Effect of endothelin on normal and diseased human coronary artery. Eur J Clin Invest 1992;22:210-3.
35. Balligand JL, Godfraind T. Effect of nisoldipine on contractions evoked by endothelin-1 in human isolated distal and proximal coronary arteries and veins. J Cardiovasc Pharmacol 1994;24:618-25.
36. Opgaard OS, Adner M, Gulbenkian S, Edvinsson L. Localization of endothelin immunoreactivity and demonstration of constrictory endothelin-A receptors in human coronary arteries and veins. J Cardiovasc Pharmacol 1994;23:576-83.
37. B receptors in canine coronary arteries. Circ Res 1994;74:105-14.
38. Nakao K, Saito Y, Matsuyama K, Okumura K, Jougasaki M, Yasue H. Implication of endothelin in variant angina [Abstract]. Circulation 1989;80:11-586.
39. Yang ZH, Richard V, von Segesser E, et al. Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. A new mechanism of vasospasm? Circulation 1990;82:188-95.
40. Nakayama K, Ishigai Y, Uchida H, Tanaka Y. Potentiation by endothelin-1 of 5-hydroxytryptamine-induced contraction in coronary artery of the pig. Br J Pharmacol 1991;104: 978-86.
41. Zeiher AM, Ihling C. Pistorius K, Schachinger V, Schaefer HE. Increased tissue endothelin immunoreactivity in atherosclerotic lesions associated with acute coronary syndromes. Lancet 1994;344:1405-6.
42. Dagassan PH, Clozel M, Breu V, Clozel JP. Role of endothelin in spontaneous phasic contraction of human coronary arteries. J Cardiovasc Pharmacol (in press).
43. Douglas SA, Louden C, Vickery Clark LM, et al. A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty. Protective effects of the novel nonpeptide endothelin receptor antagonist SB 209670. Circ Res 1994;75:190-7.
44. A receptor antagonism with BQ-123 is insufficient to inhibit angioplasty induced neointima formation in the rat. Cardiovasc Res 1995;29:641-6.